ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
about
A putative molecular network associated with colon cancer metastasis constructed from microarray data.Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.A river model to map convergent cancer evolution and guide therapy in RCC.ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer.An epigenome-wide association study of inflammatory response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer.Targeted next-generation sequencing of cancer genes in poorly differentiated thyroid cancer.A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer.Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing.Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner.HER4 isoform CYT2 and its ligand NRG1III are expressed at high levels in human colorectal cancer.
P2860
Q36409632-20EB7A0B-66D8-456B-8C2F-A781CD71BAB9Q37282490-D3A2AE40-D0BA-4FF2-844C-629F5DCCCA0EQ37725589-FB9D9F8D-58F3-4476-8571-36306E810706Q38622920-BBDA7E57-9C7E-4219-96EC-3C332BF94570Q38729111-A202BF11-AA2C-4ECE-8E00-7312DC2B2E13Q38740450-CDA5DF07-F1FC-40D5-9E88-D343177117C6Q40073257-947AAD64-701C-4C10-9532-9A118460B058Q41105157-B54E798F-9647-4340-A5E0-0A016076F979Q41718159-A883E9D2-910C-40B1-AF8C-A579501E8503Q47150624-5D8F75AC-7F36-4F45-BD30-DBB880E480EBQ47158524-314D9FD1-6E02-416F-92F6-66B7C717E1D8Q48091765-BD0A8ED6-BB1F-48AE-9087-8BCC7B2A8E19Q49339070-A286221F-34AE-4288-BFDC-8E89994910BCQ52608458-F9A33FC5-66C7-42F0-A2F7-BFADC48F9680
P2860
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
@ast
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
@en
type
label
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
@ast
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
@en
prefLabel
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
@ast
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
@en
P2093
P2860
P50
P356
P1433
P1476
ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
@en
P2093
Jessica K Bernard
Mark R Frey
Mary Kay Washington
Michelle Demory Beckler
P2860
P304
P356
10.1093/CARCIN/BGV049
P407
P577
2015-04-27T00:00:00Z